About this trial
Rehabilitation improves health outcomes, reduces disability and improves quality of life. There is a significant and emerging body of international evidence to support the benefit and cost effectiveness of specialist rehabilitation services within a modern health service. The demand for rehabilitation services is growing with changes in populations and with the advances in health care and new interventions and technology.
Our overall aim is to explore the outcomes and clinical characteristics of adults who are admitted to a rehabilitation hospital in the Midwest region of Ireland during admission, at the time of their discharge and at 6 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged 18 and over and admitted to a relevant rehabilitation unit with capacity to provide consent for inclusion.
Disqualifiers
Pregnant women and patients who are deemed not to have capacity to consent.
Trial population
All adults admitted to St Ita's Rehabilitation Hospital from February 2025 to February 2026 (inclusive) will be considered eligible for participation in the study, if they meet the inclusion criteria.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Incidence of functional decline
The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.
Incidence of functional decline
The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.
Incidence of Functional Decline
The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.
Secondary outcomes
Healthcare use
Number of services that participants were in receipt of following discharge from rehabilitation services including; GP visits, unplanned Emergency Department attendance, Outpatient appointments.
Polypharmacy level
Potentially inappropriate prescribing (PIP) and potentially omitted medications (POM) using the STOP START criteria. The STOPP/START Screening tools are based on the STOPP/START Prescription criteria which consist of a set of inappropriate combinations of medicines and disease (STOPP) and a set of recommended treatments for given conditions (START). There are 80 STOPP and 34 START criteria and they are grouped by physiological system e.g. cardiovascular.
Polypharmacy level
potentially inappropriate prescribing (PIP) and potentially omitted medications (POM) using the STOP START criteria. The STOPP/START Screening tools are based on the STOPP/START Prescription criteria which consist of a set of inappropriate combinations of medicines and disease (STOPP) and a set of recommended treatments for given conditions (START). There are 80 STOPP and 34 START criteria and they are grouped by physiological system e.g. cardiovascular.
Polypharmacy level
potentially inappropriate prescribing (PIP) and potentially omitted medications (POM) using the STOP START criteria. The STOPP/START Screening tools are based on the STOPP/START Prescription criteria which consist of a set of inappropriate combinations of medicines and disease (STOPP) and a set of recommended treatments for given conditions (START). There are 80 STOPP and 34 START criteria and they are grouped by physiological system e.g. cardiovascular.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.